The Queen Elizabeth Hospital is an acute care teaching hospital in the western suburbs of Adelaide, South Australia. It provides a range of health services, including inpatient, outpatient, surgical, emergency and mental health services.

During the past decade, The Queen Elizabeth Hospital conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 57 clinical trials were completed, i.e. on average, 62.6% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 33 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Queen Elizabeth Hospital" #1 sponsor was "Amgen" with 13 trials, followed by "Pfizer" with 12 trials sponsored, "Celgene" with 11 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored and "Janssen Research & Development, LLC" with 10 trials sponsored. Other sponsors include 115 different institutions and companies that sponsored additional 83 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Queen Elizabeth Hospital" #1 collaborator was "Medigen Biotechnology Corporation" with 4 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 3 trials as a collaborator and "Gilead Sciences" with 3 trials as a collaborator. Other collaborators include 113 different institutions and companies that were collaborators in the rest 107 trials.

According to Clinical.Site data, the most researched conditions in "The Queen Elizabeth Hospital" are "Colorectal Cancer" (8 trials), "Lymphoma" (7 trials), "Melanoma" (5 trials), "Alzheimer Disease" (4 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "The Queen Elizabeth Hospital" in a lesser frequency.

Most popular intervention types in "The Queen Elizabeth Hospital" are "Drug" (148 trials), "Biological" (22 trials), "Other" (21 trials), "Procedure" (11 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (50 trials), "Paclitaxel" (6 trials), "Guselkumab" (5 trials), "Irinotecan" (5 trials) and "Rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "The Queen Elizabeth Hospital" are 168 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "The Queen Elizabeth Hospital". undefined are not yet recruiting, 24 are recruiting, 28 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 95 completed trials in The Queen Elizabeth Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in The Queen Elizabeth Hospital, 19 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 9 trials that are defined as “Not Applicable".